Rocket Pharmaceuticals
RCKT
#8749
Rank
โ‚น20.17 B
Marketcap
โ‚น180.69
Share price
-7.58%
Change (1 day)
-31.17%
Change (1 year)

Earnings for Rocket Pharmaceuticals (RCKT)

Earnings in 2026 (TTM): -โ‚น0.23 Billion

According to Rocket Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น20.68 Billion, an increase over its 2024 earnings that were of -โ‚น23.98 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rocket Pharmaceuticals from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น0.23 Billion-98.91%
2025 -โ‚น20.68 Billion-13.77%
2024 -โ‚น23.98 Billion5.35%
2023 -โ‚น22.76 Billion10.7%
2022 -โ‚น20.56 Billion31.23%
2021 -โ‚น15.67 Billion21.02%
2020 -โ‚น12.95 Billion80.79%
2019 -โ‚น7.16 Billion3.69%
2018 -โ‚น6.91 Billion323.4%
2017 -โ‚น1.64 Billion-58.93%
2016 -โ‚น3.98 Billion-36.96%
2015 -โ‚น6.3 Billion613.27%
2014 -โ‚น0.89 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น14.47 Billion 1,709.44%๐Ÿ‡บ๐Ÿ‡ธ USA